image

The best stocks to buy since 1993

Latest issue now available

Kainos - Helping government deal with COVID-19 fallout

May 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • KNOS
  • Price:
  • 693p
Ahead of full year results due on 26 May, Kainos has said these will be reassuringly in line (Investec’s forecast is £25.5m pretax profit and eps of 17p). The company continued to generate cash from operations and has a robust balance sheet with cash balances of £40m. Over 1,700 staff have moved to home working in a seamless fashion. Several customers in government and healthcare are at the forefront of responding to the coronavirus, and digital access to essential services has become extremely important with Kainos being asked to help the government deal with the COVID-19 fall-out, ranging from amendments to the NHS app to dealing with emergency passport applications, with some senior staff working pro bono ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe